Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bendstrup (Vejle, Denmark). Drug-induced interstitial lung disease: known knowns and known unknowns. International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease

Member's Comments

No comment yet.

Related content which might interest you: Fibrosing interstitial lung diseases: knowns and unknowns Source: Eur Respir Rev, 28 (151) 180100; 10.1183/16000617.0100-2018 Year: 2019 Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns Source: ERJ Open Res, 5 (3) 00118-2019; 10.1183/23120541.00118-2019 Year: 2019 Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities? Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Interstitial lung diseases and COVID-19: myths and reality Source: Virtual Congress 2021 – Chinese programme 2021 Year: 2021 Unclassified or unclassifiable interstitial lung disease: confusing or helpful disease category? Source: Eur Respir J 2013; 42: 576-579 Year: 2013 Debate – Controversies in interstitial lung disease Source: ERS webinar 2021 Access for REGISTERED non-members Year: 2021 Unclassifiable interstitial lung disease: a distinct entity with heterogeneous progression Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Interstitial lung diseases today Source: Eur Respir Mon; 2009: 46: 1–3 Year: 2009 Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin Source: Eur Respir J 2001; 18: 17S-29S Year: 2001 Smoking-related interstitial lung diseases: a concise review Source: Eur Respir J 2001; 17: 122-132 Year: 2001 Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new Source: Breathe, 16 (4) 200223; 10.1183/20734735.0223-2020 Year: 2020 "Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease" Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Progressive fibrosing interstitial lung disease: we know it behaves badly, but what does that mean? Source: Eur Respir J, 55 (6) 2000894; 10.1183/13993003.00894-2020 Year: 2020 Interstitial lung diseases: a clinical update Source: Eur Respir J 2001; 18: 1S Year: 2001 Cystic interstitial lung disease - a rare disease? Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease Year: 2015 Sarcoidosis: an underrecognised cause for bullous lung disease? Source: Eur Respir J 2009; 34: 999-1001 Year: 2009